AlphaVest Acquisition (ATMV) 10-Q 19 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - $ / shares	9 Months Ended
	Sep. 30, 2024	Nov. 19, 2024
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	001-41574
Entity Registrant Name	ALPHAVEST ACQUISITION CORP
Entity Central Index Key	0001937891
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	205 W 37th St
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10018
City Area Code	203
Local Phone Number	998-5540
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		7,006,329
Entity Listing, Par Value Per Share	$ 0.0001
Units, each consisting of one ordinary share and one right
Title of 12(b) Security	Units, each consisting of one ordinary share and one right
Trading Symbol	ATMVU
Security Exchange Name	NASDAQ
Common stock, par value $0.0001 per share
Title of 12(b) Security	Common stock, par value $0.0001 per share
Trading Symbol	ATMV
Security Exchange Name	NASDAQ
Rights, each right entitling the holder thereof to one-tenth of one ordinary share
Title of 12(b) Security	Rights, each right entitling the holder thereof to one-tenth of one ordinary share
Trading Symbol	ATMVR
Security Exchange Name	NASDAQ

Balance Sheets

Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current Assets:
Cash	$ 7,095	$ 28,560
Prepaid expenses	21,399	34,573
Total Current Assets	28,494	63,133
Marketable securities held in trust account	53,011,509	50,880,604
Cash held in trust escrow account	55,000
Total Assets	53,095,003	50,943,737
Current Liabilities:
Accounts payable and accrued offering costs and expenses	346,209	213,118
Other payable	70,000
Due to related party	9,837	9,837
Total Current Liabilities	1,305,213	387,955
Total Liabilities	1,305,213	387,955
Commitments and contingencies
Ordinary shares subject to possible redemption (4,725,829 shares at $11.23 and $10.77 per share as of September 30, 2024 and December 31, 2023, respectively)	53,066,509	50,880,604
Shareholders’ Deficit:
Preferred shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding as of September 30, 2024 and December 31, 2023, respectively
Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 2,280,500 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	228	228
Additional paid-in capital
Accumulated deficit	(1,276,947)	(325,050)
Total Shareholders’ Deficit	(1,276,719)	(324,822)
Total Liabilities, Redeemable Ordinary Shares, and Shareholders’ Deficit	53,095,003	50,943,737
Nonrelated Party [Member]
Current Liabilities:
Promissory notes	456,000
Related Party [Member]
Current Liabilities:
Promissory notes	$ 423,167	$ 165,000

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Temproary equity, redemption shares	4,725,829	4,725,829
Temproary equity, redemption price per share	$ 11.23	$ 10.77
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	2,280,500	2,280,500
Common stock, shares outstanding	2,280,500	2,280,500

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Formation and operating costs	$ 182,580	$ 198,821	$ 566,903	$ 487,194
Loss from operations	(182,580)	(198,821)	(566,903)	(487,194)
Other Income (expenses):
Interest income on investments held in trust account	684,600	954,788	1,893,221	2,592,461
Unrealized loss on investments held in trust account			(92,316)
Bank interest income	1	21	6	175
Total other income	684,601	954,809	1,800,911	2,592,636
Net income	$ 502,021	$ 755,988	$ 1,234,008	$ 2,105,442
Redeemable Common Stock [Member]
Other Income (expenses):
Weighted average common stock outstanding, Basic	4,725,829	6,900,000	4,725,829	6,900,000
Weighted average common stock outstanding, Diluted	4,725,829	6,900,000	4,725,829	6,900,000
Basic net income per share	$ 0.13	$ 0.12	$ 0.33	$ 0.32
Diluted net income per share	$ 0.13	$ 0.12	$ 0.33	$ 0.32
Non redeemable Common Stock [Member]
Other Income (expenses):
Weighted average common stock outstanding, Basic	2,280,500	2,280,500	2,280,500	2,280,500
Weighted average common stock outstanding, Diluted	2,280,500	2,280,500	2,280,500	2,280,500
Basic net income per share	$ (0.06)	$ (0.02)	$ (0.14)	$ (0.06)
Diluted net income per share	$ (0.06)	$ (0.02)	$ (0.14)	$ (0.06)

Statements of Changes in Shareh

Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022	$ 228	$ 596,893	$ (42,578)	$ 554,543
Balance, shares at Dec. 31, 2022	2,280,500
Accretion for ordinary shares subject to redemption amount (interest income)		(596,893)	(244,327)	(841,220)
Net income			644,898	644,898
Balance at Mar. 31, 2023	$ 228		357,993	358,221
Balance, shares at Mar. 31, 2023	2,280,500
Balance at Dec. 31, 2022	$ 228	596,893	(42,578)	554,543
Balance, shares at Dec. 31, 2022	2,280,500
Net income				2,105,442
Balance at Sep. 30, 2023	$ 228		29,068	29,296
Balance, shares at Sep. 30, 2023	2,280,500
Balance at Mar. 31, 2023	$ 228		357,993	358,221
Balance, shares at Mar. 31, 2023	2,280,500
Accretion for ordinary shares subject to redemption amount (interest income)			(834,681)	(834,681)
Net income			704,556	704,556
Balance at Jun. 30, 2023	$ 228		227,868	228,096
Balance, shares at Jun. 30, 2023	2,280,500
Accretion for ordinary shares subject to redemption amount (interest income)			(954,788)	(954,788)
Net income			755,988	755,988
Balance at Sep. 30, 2023	$ 228		29,068	29,296
Balance, shares at Sep. 30, 2023	2,280,500
Balance at Dec. 31, 2023	$ 228		(325,050)	(324,822)
Balance, shares at Dec. 31, 2023	2,280,500
Accretion for ordinary shares subject to redemption amount (interest income)			(586,164)	(586,164)
Net income			349,241	349,241
Accretion for ordinary shares subject to redemption amount (extension deposit)			(55,000)	(55,000)
Balance at Mar. 31, 2024	$ 228		(616,973)	(616,745)
Balance, shares at Mar. 31, 2024	2,280,500
Balance at Dec. 31, 2023	$ 228		(325,050)	(324,822)
Balance, shares at Dec. 31, 2023	2,280,500
Net income				1,234,008
Balance at Sep. 30, 2024	$ 228		(1,276,947)	(1,276,719)
Balance, shares at Sep. 30, 2024	2,280,500
Balance at Mar. 31, 2024	$ 228		(616,973)	(616,745)
Balance, shares at Mar. 31, 2024	2,280,500
Accretion for ordinary shares subject to redemption amount (interest income)			(530,141)	(530,141)
Net income			382,746	382,746
Accretion for ordinary shares subject to redemption amount (extension deposit)			(110,000)	(110,000)
Balance at Jun. 30, 2024	$ 228		(874,368)	(874,140)
Balance, shares at Jun. 30, 2024	2,280,500
Accretion for ordinary shares subject to redemption amount (interest income)			(684,600)	(684,600)
Net income			502,021	502,021
Accretion for ordinary shares subject to redemption amount (extension deposit)			(220,000)	(220,000)
Balance at Sep. 30, 2024	$ 228		$ (1,276,947)	$ (1,276,719)
Balance, shares at Sep. 30, 2024	2,280,500

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income	$ 1,234,008	$ 2,105,442
Adjustments to reconcile net income to net cash used in operating activities:
Trust investment income	(1,893,221)	(2,592,461)
Unrealized loss on investments held in trust account	92,316
Changes in operating assets and liabilities:
Prepaid expense	94,174	67,530
Accounts payable and accrued offering costs and expenses	366,677	(181,703)
Other payable	70,000
Promissory note – related party	14,580
Net cash used in operating activities	(21,465)	(601,192)
Cash flows from investing activities:
Purchase of investment held in Trust Account	(330,000)
Cash deposited to trust escrow account	(55,000)
Net cash used in investing activities	(385,000)
Cash flows from financing activities:
Proceeds from promissory note – related party	55,000
Proceeds from promissory note – third party	330,000
Net cash provided by financing activities	385,000
Net change in cash	(21,465)	(601,192)
Cash at beginning of period	28,560	659,035
Cash at end of period	7,095	57,843
Supplemental disclosure of noncash investing and financing activities
Accretion for ordinary shares subject to redemption amount	2,185,905	2,630,689
Accrued expenses converted to promissory note– related party	188,587
Accrued expenses converted to promissory note – third party	45,000
Prepaid expenses paid by promissory note – third party	$ 81,000

ORGANIZATION AND BUSINESS OPERA

ORGANIZATION AND BUSINESS OPERATIONS	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1 - ORGANIZATION AND BUSINESS OPERATIONS AlphaVest Acquisition Corp (the “Company”) was incorporated in the Cayman Islands on January 14, 2022. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2024, the Company had not commenced any operations. All activity through September 30, 2024 relates to the Company’s formation and the initial public offering (“IPO”), which is described below, and subsequent to the IPO, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion an initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end. The registration statement for the Company’s IPO (the “Registration Statement”) was declared effective on December 19, 2022. On December 22, 2022, the Company consummated the IPO of 6,000,000 60,000,000 390,000 10.00 Following the closing of the IPO on December 22, 2022, an amount of $ 61,200,000 10.20 On December 29, 2022, EarlyBirdCapital, Inc. (“EBC”) fully exercised their over-allotment option, resulting in an additional 900,000 9,000,000 40,500 10.00 405,000 The Company will have until the last Extended Date, December 22, 2024 to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100 100,000 Extension On December 21, 2023, the Company held a special meeting of shareholders, at which the Company’s shareholders approved (i) an amendment to the Company’s amended and restated certificate of incorporation (the “Extension Amendment”) and (ii) an amendment (the “Trust Agreement Amendment”) to the Investment Management Trust Agreement, dated December 19, 2022, with Continental Stock Transfer & Trust Company. Pursuant to the Trust Agreement Amendment, the Company has extended the date by which it has to complete a business combination from December 22, 2023 (the “Termination Date”) up to 10 times, with the first extension comprised of three months, and the subsequent 9 extensions comprised of one month each from the Termination Date, or extended date, as applicable, to December 22, 2024. In connection with the shareholders’ vote at the special meeting, an aggregate of 2,174,171 23,282,936 10.71 On December 21, 2023, the Company issued a promissory note to Alphavest Holding LP, one of the Sponsors, 165,000 to cover expenses in connection with the extension of Business Combination Period. Principal of this Extension Note may be drawn down from time to time prior to the Maturity Date upon written request from the Company. On April 15, 2024, the Company amended and restated the Extension Note to increase the principal amount to $ 715,000 , 2024 On May 2, 2024, the Company issued a promissory note to a potential target, pursuant to which the Company could borrow an aggregate of $ 440,000 As of the date of this filing, an aggregate of $ 605,000 Proposed Business Combination On August 11, 2023, the Company (at and after the Merger Effective Date, “PubCo”) entered into a business combination agreement (the “Business Combination Agreement”) with AV Merger Sub, a Cayman Islands exempted company and a direct wholly owned subsidiary of the Company (“Merger Sub”), and Wanshun Technology Industrial Group Limited, a Cayman Islands exempted company (“Wanshun”). On March 18, 2024, the Company delivered to Wanshun a Notice of Termination of Business Combination (the “Termination”), in which the Business Combination Agreement was terminated pursuant to Section 8.1(e) of the Business Combination Agreement. The termination of the Business Combination Agreement is effective as of March 18, 2024. For additional information regarding the Transactions, the Business Combination Agreement, Notice of Termination of Business Combination and Wanshun, see the most recent Annual Report on Form 10-K and Current Reports on Form 8-K filed by the Company with the SEC on August 14, 2023, August 17, 2023 and March 25, 2024. On May 2, 2024, the Company issued a promissory note to AMC (defined below) (the “Extension Note 2”), pursuant to which the Company could borrow an aggregate of $ 440,000 10.00 330,000 0 On May 2, 2024, the Company issued a promissory note to AMC (the “Promissory Note 2”), pursuant to which the Company could borrow up to an aggregate of $ 126,000 10.00 126,000 0 On August 16, 2024, the Company entered into a business combination agreement (the “Merger Agreement”) with AV Merger Sub, wholly owned subsidiary of the Company (“Merger Sub”), and AMC Corporation, a Washington corporation (“AMC”). Upon the terms and subject to the conditions of the Merger Agreement, an in accordance with applicable law, Merger Sub will merge with AMC, with AMC surviving the merger as a wholly owned subsidiary of the Company. Going Concern Consideration and Management Liquidity Plans As of September 30, 2024, the Company had cash of $ 7,095 1,276,719 In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” On September 13, 2024, the Company received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company is not in compliance with Listing Rule 5450(a)(2) (the “Minimum Public Holders Rule”), which requires the Company to have at least 400 total holders for continued listing on The Nasdaq Global Market. An indicator will be displayed with quotation information related to the Company’s securities on listingcenter.nasdaq.com and may be displayed by other third-party providers of market data information, however, the Notice does not impact the listing of the Company’s securities on The Nasdaq Global Market at this time. The Notice states that the Company has 45 calendar days, or until October 28, 2024, to submit a plan (the “Company’s Plan”) to regain compliance with the Minimum Public Holders Rule. If the Company is unable to regain compliance by that date, the Company intends to submit a plan to regain compliance with the Minimum Public Holders Rule within the required timeframe. If Nasdaq accepts the Company’s Plan, Nasdaq may grant the Company an extension of up to 180 calendar days from the date of the Notice to evidence compliance with the Minimum Public Holders Rule. If Nasdaq does not accept the Company’s Plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel. However, there can be no assurance that such an appeal would be successful. The Company, by filing this Current Report Form 8-K, discloses its receipt of the Notice in accordance with Nasdaq Listing Rule 5810(b). The Company intends to monitor its total holders between now and October 28, 2024, and may, if appropriate, evaluate available options to resolve the deficiency under the Minimum Public Holders Rule and regain compliance with the Minimum Public Holders Rule. Additionally, the Company may consider applying to transfer the listing of its securities to The Nasdaq Capital Market (provided that it then satisfies the requirements for continued listing on that market). However, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing criteria. The Company submitted the Company’s Plan on October 28, 2024 to transfer the listing of our Ordinary Shares, Units and Rights from the Nasdaq Global Market to the Nasdaq Capital Market. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the requirements of the U.S. Securities and Exchange Commission (“SEC”) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These unaudited financial statements have been prepared on the same basis as the Company’s annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2024, or for any other interim period or for any other future year. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash balance of $ 7,095 28,560 Investments Held in Trust Account The Company’s portfolio of investments held in the trust account is comprised of investments only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company’s investments held in the trust account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in trust account are included in interest earned on marketable securities held in trust account in the accompanying statements of operations. The estimated fair value of investments held in the trust account is determined using available market information. As of September 30, 2024 and December 31, 2023, the trust account had balance of $ 53,011,509 50,880,604 684,600 954,788 1,893,221 and $ 2,592,461 Cash held in Trust Escrow Account As of September 30, 2024, the Company had $ 55,000 Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “ Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no no There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement. Net Income (Loss) per Ordinary Shares The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of June 30, 2024, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented. The net income (loss) per share presented in the statements of operations is based on the following: SCHEDULE OF NET INCOME (LOSS) PER SHARE 2024 2023 2024 2023 Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Net income $ 502,021 $ 755,988 $ 1,234,008 $ 2,105,442 Accretion of temporary equity into redemption value (interest earned) (684,600 ) (954,788 ) (1,800,904 ) (2,630,689 ) Accretion of temporary equity into redemption value (extension deposit) (220,000 ) - (385,000 ) - Net loss including accretion of equity into redemption value $ (402,579 ) $ (198,800 ) $ (951,896 ) $ (525,247 ) Particulars Shares Shares Shares Shares Shares Shares Shares Shares For Three Months Ended For Nine Months Ended For Three Months Ended For Nine Months Ended Redeemable Non-Redeemable Redeemable Non-Redeemable Redeemable Non-Redeemable Redeemable Non-Redeemable Particulars Shares Shares Shares Shares Shares Shares Shares Shares Basic and diluted net income/(loss) per share: Weighted-average shares outstanding 4,725,829 2,280,500 4,725,829 2,280,500 6,900,000 2,280,500 6,900,000 2,280,500 Ownership percentage 67 % 33 % 67 % 33 % 75 % 25 % 75 % 25 % Numerators: Allocation of net loss including accretion of temporary equity (271,543 ) (131,036 ) (642,062 ) (309,834 ) (149,417 ) (49,383 ) (394,772 ) (130,475 ) Interest earned on investment held in trust account 684,600 - 1,800,904 - 954,788 - 2,630,689 - Accretion of temporary equity into redemption value (extension deposit) 220,000 - 385,000 - - - - - Allocation of net income/(loss) 633,057 (131,036 ) 1,543,842 (309,834 ) 805,371 (49,383 ) 2,235,917 (130,475 ) Denominators: Weighted-average shares outstanding 4,725,829 2,280,500 4,725,829 2,280,500 6,900,000 2,280,500 6,900,000 2,280,500 Basic and diluted net income/(loss) per share $ 0.13 $ (0.06 ) $ 0.33 $ (0.14 ) $ 0.12 $ (0.02 ) $ 0.32 $ (0.06 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $ 250,000 Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “ Fair Value Measurement Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC 480 “ Distinguishing Liabilities from Equity December 31, 2023 , the ordinary shares subject to possible redemption in the amount of $ 53,066,509 50,880,604 At September 30, 2024, the ordinary shares reflected in the balance sheets are reconciled in the following table: SCHEDULE OF INITIAL PUBLIC OFFERING PROCEEDS TO COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION Ordinary shares subject to possible redemption at December 31, 2023 $ 50,880,604 Plus: Accretion for ordinary shares subject to redemption (income earned on investment held in trust account) 586,164 Accretion for ordinary shares subject to redemption (extension deposit) 55,000 Ordinary shares subject to possible redemption at March 31, 2024 51,521,768 Plus: Accretion for ordinary shares subject to redemption (income earned on investment held in trust account) 530,141 Accretion for ordinary shares subject to redemption (extension deposit) 110,000 Ordinary shares subject to possible redemption at June 30, 2024 $ 52,161,909 Plus: Accretion for ordinary shares subject to redemption (income earned on investment held in trust account) 684,600 Accretion for ordinary shares subject to redemption (extension deposit) 220,000 Ordinary shares subject to possible redemption at September 30, 2024 $ 53,066,509 Convertible Promissory Note The Company adopted the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) and accounts for its convertible promissory notes as debt (liability) on the balance sheet. The Company’s assessment of the embedded conversion feature (see Note 1 - Organization and Business Operations) considers the derivative scope exception guidance under ASC 815 pertaining to equity classification of contracts in an entity’s own equity. The conversion feature of these promissory notes meets the definition of a derivative instrument. However, bifurcation of conversion feature from the debt host is not required because the conversion feature meets ASC 815 scope exception, as the promissory notes are convertible in shares of the Company’s common stock which is considered indexed to the Company’s own stock and classified in stockholders’ equity. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	9 Months Ended
	Sep. 30, 2024
Initial Public Offering
INITIAL PUBLIC OFFERING	NOTE 3 - INITIAL PUBLIC OFFERING Pursuant to the IPO, the Company sold 6,000,000 10.00 Each Unit consists of one share of ordinary shares and one right to receive one-tenth (1/10) of one ordinary shares upon the consummation of the Company’s initial business combination one right (“Public Right”). 900,000 9,000,000

PRIVATE PLACEMENTS

PRIVATE PLACEMENTS	9 Months Ended
	Sep. 30, 2024
Private Placements
PRIVATE PLACEMENTS	NOTE 4 - PRIVATE PLACEMENTS Simultaneously with the closing of the IPO, the Company consummated the private sale of 390,000 Each Unit consists of one share of ordinary shares and one right to receive one-tenth (1/10) of one share of ordinary shares upon the consummation of the Company’s initial business combination (“Private Right”). In connection with EBC’s full exercise of their over-allotment option, the Company also consummated the sale of an additional 40,500 10.00 405,000

RELATED PARTIES

RELATED PARTIES	9 Months Ended
	Sep. 30, 2024
Related Party Transactions [Abstract]
RELATED PARTIES	NOTE 5 - RELATED PARTIES On February 7, 2022, the sponsor received 1,725,000 25,000 225,000 On April 18, 2023, AlphaVest Holding LP, one of our sponsors, transferred an aggregate of 1,035,000 The Sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) six months after the completion of the initial Business Combination and (B) the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction after our initial business combination that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. As of September 30, 2024 and December 31, 2023, the amounts due to related parties were $ 433,004 174,837 Administrative Services Agreement Commencing on the date the Units are first listed on the Nasdaq, the Company has agreed to pay TenX Global Capital LP a total of $ 10,000 30,000 90,000 103,871 30,000 90,000 Promissory Notes - Related Party On June 3, 2022, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate of $ 150,000 0 On December 21, 2023, Alphavest Holding LP, one of the Sponsor, agreed to loan the Company $ 165,000 715,000 715,000 , 2024 promptly after the date of the consummation of the business combination. As of September 30, 2024 and December 31, 2023, $ 220,000 and $ 165,000 On March 12, 2024, the Company issued a promissory note to TenX Global Capital LP (the “Promissory Note 1”), pursuant to which the Company could borrow up to an aggregate of $ 400,000 On October 21, 2024, the Company amended and restated the Promissory Note with AlphaVest Holding LP to extend the maturity date to the earlier of: (i) December 12, 2024 or (ii) promptly after the date of the consummation of the business combination. 203,167 0 Website Service On February 22, 2024 and 2023, the Company has agreed to pay TenX Global Capital LP a total of $ 537 784 134 198 425 and $ 436

COMMITMENTS AND CONTINGENCY

COMMITMENTS AND CONTINGENCY	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCY	NOTE 6 - COMMITMENTS AND CONTINGENCY Registration Rights The holders of the Founder Shares, ordinary shares issued to EBC, Private Placement Units and Units that may be issued upon conversion of Working Capital Loans (and all underlying securities) will be entitled to registration rights pursuant to a registration rights agreement signed prior to or on the effective date of Proposed Public Offering requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company and EBC signed an engagement letter which was amended on September 15, 2022, pursuant to which, the Company will grant EBC 45-day option from the date of Proposed Public Offering to purchase up to 900,000 1,725,000 Business Combination Marketing Agreement The Company has engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with the Company stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and public filings in connection with the Business Combination. The Company will pay EBC a cash fee for such services upon the consummation of its initial business combination in an amount equal to 3.5 2,415,000 1.0

SHAREHOLDERS_ EQUITY

SHAREHOLDERS’ EQUITY	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
SHAREHOLDERS’ EQUITY	NOTE 7 - SHAREHOLDERS’ EQUITY Preference Shares 2,000,000 0.0001 no Ordinary Shares 200,000,000 0.0001 On February 7, 2022, the Sponsor received 1,725,000 ordinary shares in exchange for $ 25,000 1,725,000 225,000 20 shares after the Public Offering (excluding Private Shares). On July 11, 2022, EBC received an aggregate of 125,000 1,750 0.014 1,812 On December 22, 2022, the Sponsor and EBC received an aggregate of 390,000 365,000 25,000 10.00 3,900,000 On December 29, 2022, as a result of the EBC’s election to fully exercise their over-allotment option, the Sponsor and EBC received additional 40,500 37,904 2,596 10.00 As of September 30, 2024 and December 31, 2023, there were 2,280,500 4,725,829 subject to possible redemption which are presented as temporary equity as of September 30, 2024 and December 31, 2023. Rights -

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 8 - FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2024 and December 31, 2023. and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. At September 30, 2024, the Company has recognized the unrealizes loss of $ 92,316 SCHEDULE OF ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS Date Trading Securities Level Fair Value September 30, 2024 Marketable securities held in the trust account 1 $ 53,011,509 December 31, 2023 Marketable securities held in the trust account 1 $ 50,880,604

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9 - SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were available to be issued. Based upon this review, the Company identified the following subsequent event that is required disclosure in the financial statements. On October 11, 2024, the Company issued a promissory note to AMC (the “Promissory Note 3”), pursuant to which the Company could borrow up to an aggregate of $ 100,000 10.00 54,285 As previously disclosed in Note 1, the Company received a written notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company is not in compliance with Listing Rule 5450(a)(2) (the “Minimum Public Holders Rule”), which requires the Company to have at least 400 total holders for continued listing on The Nasdaq Global Market. On October 28, 2024, the Company submitted a plan to transfer the listing of our Ordinary Shares, Units and Rights from the Nasdaq Global Market to the Nasdaq Capital Market.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the requirements of the U.S. Securities and Exchange Commission (“SEC”) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These unaudited financial statements have been prepared on the same basis as the Company’s annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2024, or for any other interim period or for any other future year.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and cash equivalents	Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash balance of $ 7,095 28,560
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments held in the trust account is comprised of investments only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company’s investments held in the trust account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in trust account are included in interest earned on marketable securities held in trust account in the accompanying statements of operations. The estimated fair value of investments held in the trust account is determined using available market information. As of September 30, 2024 and December 31, 2023, the trust account had balance of $ 53,011,509 50,880,604 684,600 954,788 1,893,221 and $ 2,592,461
Cash held in Trust Escrow Account	Cash held in Trust Escrow Account As of September 30, 2024, the Company had $ 55,000
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “ Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no no There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement.
Net Income (Loss) per Ordinary Shares	Net Income (Loss) per Ordinary Shares The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of June 30, 2024, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented. The net income (loss) per share presented in the statements of operations is based on the following: SCHEDULE OF NET INCOME (LOSS) PER SHARE 2024 2023 2024 2023 Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Net income $ 502,021 $ 755,988 $ 1,234,008 $ 2,105,442 Accretion of temporary equity into redemption value (interest earned) (684,600 ) (954,788 ) (1,800,904 ) (2,630,689 ) Accretion of temporary equity into redemption value (extension deposit) (220,000 ) - (385,000 ) - Net loss including accretion of equity into redemption value $ (402,579 ) $ (198,800 ) $ (951,896 ) $ (525,247 ) Particulars Shares Shares Shares Shares Shares Shares Shares Shares For Three Months Ended For Nine Months Ended For Three Months Ended For Nine Months Ended Redeemable Non-Redeemable Redeemable Non-Redeemable Redeemable Non-Redeemable Redeemable Non-Redeemable Particulars Shares Shares Shares Shares Shares Shares Shares Shares Basic and diluted net income/(loss) per share: Weighted-average shares outstanding 4,725,829 2,280,500 4,725,829 2,280,500 6,900,000 2,280,500 6,900,000 2,280,500 Ownership percentage 67 % 33 % 67 % 33 % 75 % 25 % 75 % 25 % Numerators: Allocation of net loss including accretion of temporary equity (271,543 ) (131,036 ) (642,062 ) (309,834 ) (149,417 ) (49,383 ) (394,772 ) (130,475 ) Interest earned on investment held in trust account 684,600 - 1,800,904 - 954,788 - 2,630,689 - Accretion of temporary equity into redemption value (extension deposit) 220,000 - 385,000 - - - - - Allocation of net income/(loss) 633,057 (131,036 ) 1,543,842 (309,834 ) 805,371 (49,383 ) 2,235,917 (130,475 ) Denominators: Weighted-average shares outstanding 4,725,829 2,280,500 4,725,829 2,280,500 6,900,000 2,280,500 6,900,000 2,280,500 Basic and diluted net income/(loss) per share $ 0.13 $ (0.06 ) $ 0.33 $ (0.14 ) $ 0.12 $ (0.02 ) $ 0.32 $ (0.06 )
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $ 250,000
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “ Fair Value Measurement
Ordinary Shares Subject to Possible Redemption	Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC 480 “ Distinguishing Liabilities from Equity December 31, 2023 , the ordinary shares subject to possible redemption in the amount of $ 53,066,509 50,880,604 At September 30, 2024, the ordinary shares reflected in the balance sheets are reconciled in the following table: SCHEDULE OF INITIAL PUBLIC OFFERING PROCEEDS TO COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION Ordinary shares subject to possible redemption at December 31, 2023 $ 50,880,604 Plus: Accretion for ordinary shares subject to redemption (income earned on investment held in trust account) 586,164 Accretion for ordinary shares subject to redemption (extension deposit) 55,000 Ordinary shares subject to possible redemption at March 31, 2024 51,521,768 Plus: Accretion for ordinary shares subject to redemption (income earned on investment held in trust account) 530,141 Accretion for ordinary shares subject to redemption (extension deposit) 110,000 Ordinary shares subject to possible redemption at June 30, 2024 $ 52,161,909 Plus: Accretion for ordinary shares subject to redemption (income earned on investment held in trust account) 684,600 Accretion for ordinary shares subject to redemption (extension deposit) 220,000 Ordinary shares subject to possible redemption at September 30, 2024 $ 53,066,509
Convertible Promissory Note	Convertible Promissory Note The Company adopted the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) and accounts for its convertible promissory notes as debt (liability) on the balance sheet. The Company’s assessment of the embedded conversion feature (see Note 1 - Organization and Business Operations) considers the derivative scope exception guidance under ASC 815 pertaining to equity classification of contracts in an entity’s own equity. The conversion feature of these promissory notes meets the definition of a derivative instrument. However, bifurcation of conversion feature from the debt host is not required because the conversion feature meets ASC 815 scope exception, as the promissory notes are convertible in shares of the Company’s common stock which is considered indexed to the Company’s own stock and classified in stockholders’ equity.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
SCHEDULE OF NET INCOME (LOSS) PER SHARE	The net income (loss) per share presented in the statements of operations is based on the following: SCHEDULE OF NET INCOME (LOSS) PER SHARE 2024 2023 2024 2023 Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Net income $ 502,021 $ 755,988 $ 1,234,008 $ 2,105,442 Accretion of temporary equity into redemption value (interest earned) (684,600 ) (954,788 ) (1,800,904 ) (2,630,689 ) Accretion of temporary equity into redemption value (extension deposit) (220,000 ) - (385,000 ) - Net loss including accretion of equity into redemption value $ (402,579 ) $ (198,800 ) $ (951,896 ) $ (525,247 ) Particulars Shares Shares Shares Shares Shares Shares Shares Shares For Three Months Ended For Nine Months Ended For Three Months Ended For Nine Months Ended Redeemable Non-Redeemable Redeemable Non-Redeemable Redeemable Non-Redeemable Redeemable Non-Redeemable Particulars Shares Shares Shares Shares Shares Shares Shares Shares Basic and diluted net income/(loss) per share: Weighted-average shares outstanding 4,725,829 2,280,500 4,725,829 2,280,500 6,900,000 2,280,500 6,900,000 2,280,500 Ownership percentage 67 % 33 % 67 % 33 % 75 % 25 % 75 % 25 % Numerators: Allocation of net loss including accretion of temporary equity (271,543 ) (131,036 ) (642,062 ) (309,834 ) (149,417 ) (49,383 ) (394,772 ) (130,475 ) Interest earned on investment held in trust account 684,600 - 1,800,904 - 954,788 - 2,630,689 - Accretion of temporary equity into redemption value (extension deposit) 220,000 - 385,000 - - - - - Allocation of net income/(loss) 633,057 (131,036 ) 1,543,842 (309,834 ) 805,371 (49,383 ) 2,235,917 (130,475 ) Denominators: Weighted-average shares outstanding 4,725,829 2,280,500 4,725,829 2,280,500 6,900,000 2,280,500 6,900,000 2,280,500 Basic and diluted net income/(loss) per share $ 0.13 $ (0.06 ) $ 0.33 $ (0.14 ) $ 0.12 $ (0.02 ) $ 0.32 $ (0.06 )
SCHEDULE OF INITIAL PUBLIC OFFERING PROCEEDS TO COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION	At September 30, 2024, the ordinary shares reflected in the balance sheets are reconciled in the following table: SCHEDULE OF INITIAL PUBLIC OFFERING PROCEEDS TO COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION Ordinary shares subject to possible redemption at December 31, 2023 $ 50,880,604 Plus: Accretion for ordinary shares subject to redemption (income earned on investment held in trust account) 586,164 Accretion for ordinary shares subject to redemption (extension deposit) 55,000 Ordinary shares subject to possible redemption at March 31, 2024 51,521,768 Plus: Accretion for ordinary shares subject to redemption (income earned on investment held in trust account) 530,141 Accretion for ordinary shares subject to redemption (extension deposit) 110,000 Ordinary shares subject to possible redemption at June 30, 2024 $ 52,161,909 Plus: Accretion for ordinary shares subject to redemption (income earned on investment held in trust account) 684,600 Accretion for ordinary shares subject to redemption (extension deposit) 220,000 Ordinary shares subject to possible redemption at September 30, 2024 $ 53,066,509

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
SCHEDULE OF ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2024 and December 31, 2023. and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. At September 30, 2024, the Company has recognized the unrealizes loss of $ 92,316 SCHEDULE OF ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS Date Trading Securities Level Fair Value September 30, 2024 Marketable securities held in the trust account 1 $ 53,011,509 December 31, 2023 Marketable securities held in the trust account 1 $ 50,880,604

ORGANIZATION AND BUSINESS OPE_2

ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative) - USD ($)					3 Months Ended						9 Months Ended
	May 02, 2024	Dec. 21, 2023	Dec. 29, 2022	Dec. 22, 2022	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Nov. 14, 2024	Apr. 15, 2024	Dec. 31, 2023
Subsidiary, Sale of Stock [Line Items]
Investment of cash in trust account				$ 61,200,000
Cash deposited in trust account per unit				$ 10.20
Redemption ordinary per share		$ 10.71
Percentage of public shares that would not be redeemed if business combination is not completed within combination period											100%
Expenses payable on dissolution					$ 100,000						$ 100,000
Shares with redemption		2,174,171
Values with redemption		$ 23,282,936			(684,600)	$ (530,141)	$ (586,164)	$ (954,788)	$ (834,681)	$ (841,220)
Escrow Deposit					55,000						55,000
Cash					7,095						7,095			28,560
Working capital deficit					1,276,719						1,276,719
Related Party [Member]
Subsidiary, Sale of Stock [Line Items]
Loan borrowed					423,167						423,167			165,000
Subsequent Event [Member]
Subsidiary, Sale of Stock [Line Items]
Escrow Deposit												$ 605,000
Promissory Note [Member]
Subsidiary, Sale of Stock [Line Items]
Loan borrowed	$ 440,000	$ 165,000
Principal amount													$ 715,000
Extension Note Two [Member]
Subsidiary, Sale of Stock [Line Items]
Loan borrowed	$ 440,000
Conversion price	$ 10
Extension Note Two [Member] | Related Party [Member]
Subsidiary, Sale of Stock [Line Items]
Loan borrowed					330,000						330,000			0
Promissory Note 2 [Member]
Subsidiary, Sale of Stock [Line Items]
Loan borrowed	$ 126,000
Conversion price	$ 10
Promissory Note 2 [Member] | Related Party [Member]
Subsidiary, Sale of Stock [Line Items]
Loan borrowed					$ 126,000						$ 126,000			$ 0
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, shares				6,000,000							6,000,000
Proceeds from sale of units				$ 60,000,000
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Number of additional private units issued				390,000							390,000
Redemption ordinary per share				$ 10
Private Placement [Member] | Sponsor [Member]
Subsidiary, Sale of Stock [Line Items]
Number of additional private units issued				390,000
Sale of stock, price per share				$ 10
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, shares			900,000
Number of additional private units issued			40,500
Sale of stock, price per share					$ 10						$ 10
Units issued during the period shares			900,000
Units issued aggregate amount			$ 9,000,000
Redemption ordinary per share			$ 10
Proceeds from issuance of private units			$ 405,000

SCHEDULE OF NET INCOME (LOSS) P

SCHEDULE OF NET INCOME (LOSS) PER SHARE (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Net income	$ 502,021	$ 382,746	$ 349,241	$ 755,988	$ 704,556	$ 644,898	$ 1,234,008	$ 2,105,442
Accretion of temporary equity into redemption value (interest earned)	(684,600)			(954,788)			(1,800,904)	(2,630,689)
Accretion of temporary equity into redemption value (extension deposit)	(220,000)						(385,000)
Net loss including accretion of equity into redemption value	$ (402,579)			$ (198,800)			$ (951,896)	$ (525,247)
Redeemable Common Stock [Member]
Ownership percentage	67%			75%			67%	75%
Non redeemable Common Stock [Member]
Ownership percentage	33%			25%			33%	25%
Redeemable Common Stock [Member]
Weighted-average shares outstanding	4,725,829			6,900,000			4,725,829	6,900,000
Allocation of net loss including accretion of temporary equity	$ (271,543)			$ (149,417)			$ (642,062)	$ (394,772)
Interest earned on investment held in trust account	684,600			954,788			1,800,904	2,630,689
Accretion of temporary equity into redemption value (extension deposit)	220,000						385,000
Allocation of net income/(loss)	$ 633,057			$ 805,371			$ 1,543,842	$ 2,235,917
Weighted-average shares outstanding	4,725,829			6,900,000			4,725,829	6,900,000
Basic net income/(loss) per share	$ 0.13			$ 0.12			$ 0.33	$ 0.32
Diluted net income/(loss) per share	$ 0.13			$ 0.12			$ 0.33	$ 0.32
Non redeemable Common Stock [Member]
Weighted-average shares outstanding	2,280,500			2,280,500			2,280,500	2,280,500
Allocation of net loss including accretion of temporary equity	$ (131,036)			$ (49,383)			$ (309,834)	$ (130,475)
Interest earned on investment held in trust account
Accretion of temporary equity into redemption value (extension deposit)
Allocation of net income/(loss)	$ (131,036)			$ (49,383)			$ (309,834)	$ (130,475)
Weighted-average shares outstanding	2,280,500			2,280,500			2,280,500	2,280,500
Basic net income/(loss) per share	$ (0.06)			$ (0.02)			$ (0.14)	$ (0.06)
Diluted net income/(loss) per share	$ (0.06)			$ (0.02)			$ (0.14)	$ (0.06)

SCHEDULE OF INITIAL PUBLIC OFFE

SCHEDULE OF INITIAL PUBLIC OFFERING PROCEEDS TO COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024
Accounting Policies [Abstract]
Balance	$ 52,161,909	$ 51,521,768	$ 50,880,604
Accretion for ordinary shares subject to redemption (income earned on investment held in trust account)	684,600	530,141	586,164
Accretion for ordinary shares subject to redemption (extension deposit)	220,000	110,000	55,000
Balance	$ 53,066,509	$ 52,161,909	$ 51,521,768

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Cash	$ 7,095		$ 7,095		$ 28,560
Trust account balance	53,011,509		53,011,509		50,880,604
Interest earned from the trust account	684,600	$ 954,788	1,893,221	$ 2,592,461
Cash held in trust escrow account not yet deposited	55,000		55,000
Unrecognized tax benefits	0		0		0
Accrued for interest and penalties	0		0		0
Federal Depository Insurance Coverage	250,000		250,000
Common Stock Subject to Mandatory Redemption [Member]
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Common stock subject to possible redemption value	$ 53,066,509		$ 53,066,509		$ 50,880,604

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details Narrative) - USD ($)			9 Months Ended
	Dec. 29, 2022	Dec. 22, 2022	Sep. 30, 2024
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued		6,000,000	6,000,000
Sale of stock, description of transaction			Each Unit consists of one share of ordinary shares and one right to receive one-tenth (1/10) of one ordinary shares upon the consummation of the Company’s initial business combination one right (“Public Right”).
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued	900,000
Sale of stock, price per share			$ 10
Number of shares issued, value	$ 9,000,000

PRIVATE PLACEMENTS (Details Nar

PRIVATE PLACEMENTS (Details Narrative) - USD ($)			9 Months Ended
	Dec. 29, 2022	Dec. 22, 2022	Sep. 30, 2024	Dec. 21, 2023
Subsidiary, Sale of Stock [Line Items]
Number of private units issued, price per share				$ 10.71
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Number of additional private units issued		390,000	390,000
Sale of stock, description			Each Unit consists of one share of ordinary shares and one right to receive one-tenth (1/10) of one share of ordinary shares upon the consummation of the Company’s initial business combination (“Private Right”).
Number of private units issued, price per share		$ 10
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Number of additional private units issued	40,500
Number of private units issued, price per share	$ 10
Proceeds from issuance of private units	$ 405,000

RELATED PARTIES (Details Narrat

RELATED PARTIES (Details Narrative) - USD ($)

3 Months Ended

9 Months Ended

Feb. 22, 2024

Dec. 21, 2023

Feb. 22, 2023

Dec. 29, 2022

Jun. 03, 2022

Feb. 07, 2022

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Apr. 15, 2024

Mar. 12, 2024

Dec. 31, 2023

Apr. 18, 2023

Related Party Transaction [Line Items]

Due to related party

$ 433,004

$ 433,004

$ 174,837

Professional Fees

30,000

$ 30,000

90,000

$ 90,000

Administrative expense outstanding

103,871

103,871

Unsecured promissory note

$ 150,000

Outstanding balance

0

0

0

Annual website service fees

$ 537

$ 784

134

$ 198

425

$ 436

Related Party [Member]

Related Party Transaction [Line Items]

Loan borrowed

423,167

423,167

165,000

TenX Global Capital LP [Member]

Related Party Transaction [Line Items]

Maximum borrowing capacity

$ 400,000

Loan borrowed

203,167

203,167

0

Extension Note [Member]

Related Party Transaction [Line Items]

Loan borrowed

$ 165,000

$ 715,000

Amount drawdowns used for extension payments

$ 715,000

Extension Note [Member] | Related Party [Member]

Related Party Transaction [Line Items]

Loan borrowed

$ 220,000

220,000

$ 165,000

AlphaVest Holding, LP [Member] | Peace Capital Limited [Member]

Related Party Transaction [Line Items]

Transferred shares

1,035,000

Over-Allotment Option [Member]

Related Party Transaction [Line Items]

Sale of stock, number of shares issued

40,500

Founder Shares [Member]

Related Party Transaction [Line Items]

Deferred offering costs

$ 25,000

Founder Shares [Member] | Over-Allotment Option [Member] | Maximum [Member]

Related Party Transaction [Line Items]

Shares subject to forfeiture to underwriters

225,000

TenX Global Capital LP [Member]

Related Party Transaction [Line Items]

Selling, General and Administrative Expense

$ 10,000

Common Stock [Member] | Over-Allotment Option [Member] | Maximum [Member]

Related Party Transaction [Line Items]

Shares subject to forfeiture to underwriters

225,000

Common Stock [Member] | Founder Shares [Member]

Related Party Transaction [Line Items]

Sale of stock, number of shares issued

1,725,000

COMMITMENTS AND CONTINGENCY (De

COMMITMENTS AND CONTINGENCY (Details Narrative) - USD ($)				9 Months Ended
	Dec. 29, 2022	Dec. 22, 2022	Sep. 15, 2022	Sep. 30, 2024
Subsidiary, Sale of Stock [Line Items]
Payment of cash underwriting discount	$ 1,725,000
Percentage of cash fee on consideration payable in initial business combination				1%
Sponsor [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from initial public offering				$ 2,415,000
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Additional units to cover over-allotments			900,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Percentage of cash fee upon initial business combination on gross proceeds				3.50%
Proceeds from initial public offering		$ 60,000,000

SHAREHOLDERS_ EQUITY (Details N

SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)					9 Months Ended
	Dec. 29, 2022	Dec. 22, 2022	Jul. 11, 2022	Feb. 07, 2022	Sep. 30, 2024	Dec. 31, 2023	Dec. 21, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized					2,000,000	2,000,000
Preferred stock par or stated value per share					$ 0.0001	$ 0.0001
Preferred stock, shares issued					0	0
Preferred stock, shares outstanding					0	0
Common stock, shares authorized					200,000,000	200,000,000
Common stock par or stated value per share					$ 0.0001	$ 0.0001
Number of shares issued, price per share							$ 10.71
Common stock, shares issued					2,280,500	2,280,500
Common stock, shares outstanding					2,280,500	2,280,500
Temproary equity, redemption shares					4,725,829	4,725,829
Over-Allotment Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued	40,500
Aggregate purchase price	$ 405,000
Number of shares issued, price per share	$ 10
Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued		390,000			390,000
Number of shares issued, price per share		$ 10
Proceeds from issuance of private placement		$ 3,900,000
Founder Shares [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Deferred offering costs				$ 25,000
Founder Shares [Member] | Over-Allotment Option [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares subject to forfeiture to underwriters				225,000
EBC Founder Shares [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued			125,000
Aggregate purchase price			$ 1,750
Number of shares issued, price per share			$ 0.014
Estimated fair value			$ 1,812
EBC Founder Shares [Member] | Over-Allotment Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued	2,596
EBC Founder Shares [Member] | Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued		25,000
Sponsor [Member] | Over-Allotment Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued	37,904
Sponsor [Member] | Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued		365,000
Common Stock [Member] | Over-Allotment Option [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares subject to forfeiture to underwriters				225,000
Common Stock [Member] | Founder Shares [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued				1,725,000
Percentage of common stock issued and outstanding				20%

SCHEDULE OF ASSETS MEASURED AT

SCHEDULE OF ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities held in the trust account	$ 53,011,509	$ 50,880,604
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities held in the trust account	$ 53,011,509	$ 50,880,604

Fair Value Measurements (Detail

Fair Value Measurements (Details Narrative)	9 Months Ended
	Sep. 30, 2024 USD ($)
Fair Value Disclosures [Abstract]
Unrealizes loss recognized	$ 92,316

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Oct. 11, 2024	Nov. 14, 2024	Sep. 30, 2024	Dec. 31, 2023
Related Party [Member]
Subsequent Event [Line Items]
Loan borrowed			$ 423,167	$ 165,000
Promissory Note 3 [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Loan borrowed	$ 100,000
Conversion price	$ 10
Promissory Note 3 [Member] | Subsequent Event [Member] | Related Party [Member]
Subsequent Event [Line Items]
Loan borrowed		$ 54,285